| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/11/1994 | WO1994009762A1 Drug delivery device |
| 05/11/1994 | WO1994002107A3 Method and medicament for inhibiting neutrophil elastase and cathepsin g |
| 05/11/1994 | EP0596490A2 Stereoselective reduction of ketones |
| 05/11/1994 | EP0596449A2 Serotonin receptor antagonists for treating myocardial ischemia |
| 05/11/1994 | EP0596406A1 Imidazo (1,2-a) Pyridines as bradykinin antagonists |
| 05/11/1994 | EP0596350A1 Cyclopeptides |
| 05/11/1994 | EP0596326A1 Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing the same, use thereof and precesses for their production |
| 05/11/1994 | EP0596058A1 Biphenylylquinuclidine derivatives as squalene synthase inhibitors |
| 05/11/1994 | EP0596057A1 Quinuclidine derivatives as squalene synthase inhibitors |
| 05/11/1994 | EP0595924A1 Platelet activating factor antagonists |
| 05/11/1994 | EP0595878A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 05/11/1994 | CA2148504A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/11/1994 | CA2148357A1 Use of 17.alpha.-dihydroequilenin for lowering cholesterol |
| 05/11/1994 | CA2148002A1 1,2,3,5,6,7,8,8a-octahydro-5,5,8a-trimethyl-(8a.beta.)-6- isoquino lineamine derivatives, preparation method therefor and therapeutical usethereof |
| 05/11/1994 | CA2147866A1 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
| 05/11/1994 | CA2147862A1 Drug delivery device |
| 05/11/1994 | CA2147754A1 Compositions and methods for modifying the regulatory activity of tgf- .beta. |
| 05/11/1994 | CA2147357A1 Methods and compositions (+) doxazosin for the treatment of hypertension |
| 05/11/1994 | CA2146767A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 05/11/1994 | CA2144161A1 Novel vitamin d analogues |
| 05/11/1994 | CA2136076A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| 05/11/1994 | CA2104060A1 Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents |
| 05/10/1994 | US5310930 Cyclization of the carboximidate salt |
| 05/10/1994 | US5310929 Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
| 05/10/1994 | US5310927 Hypotensive agents; cognition activators; imidazolyl-2-aryl derivatives |
| 05/10/1994 | US5310757 3,3,5-trimethylcyclohexyl 2-methylpropionate derivatives, their method of preparation and therapeutic compositions in which they are present |
| 05/10/1994 | US5310756 Aryloxyphenylpropylamines and their calcium overload blocking compositions and methods of use |
| 05/10/1994 | US5310744 Quinolylmethoxyphenyl-acetamides |
| 05/10/1994 | US5310740 Renin inhibitors |
| 05/10/1994 | US5310666 Process for the enantioselective preparation of (β-1)-hydroxyalkylxanthines by reduction using Rhodotorula rubra |
| 05/10/1994 | CA1329446C Peptides with laminin activity |
| 05/10/1994 | CA1329398C Compound active in cardiovascular therapy |
| 05/10/1994 | CA1329363C Apparatus for delivering nitroglycerin to the skin, process for the production thereof and the use thereof |
| 05/06/1994 | CA2109392A1 Composition and method for reducing the risk of hypotension |
| 05/06/1994 | CA2103932A1 Stereoselective reduction of ketones |
| 05/05/1994 | CA2108245A1 Method for treating myocardial ischemia employing serotonin receptor antagonists |
| 05/04/1994 | EP0595635A1 Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors |
| 05/04/1994 | EP0595610A1 Benzo-fused lactams |
| 05/04/1994 | EP0595557A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 05/04/1994 | EP0595183A1 Hydantoin derivatives, salts thereof and maillard reaction inhibitors comprising the same |
| 05/04/1994 | EP0595164A1 4-heterocyclephenyl substituted dihydropyridines |
| 05/04/1994 | EP0595151A2 Imidazopyridine derivates as antagonists of angiotensin II |
| 05/04/1994 | EP0594636A1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 05/04/1994 | EP0594611A1 Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use |
| 05/04/1994 | EP0594593A1 Therapeutically useful heterocyclic indole compounds |
| 05/04/1994 | EP0594588A1 Cycloalkyl-substituted glutaramide antihypertensive agents |
| 05/04/1994 | EP0434832B1 D8- and D9-PROSTAGLANDINE DERIVATES, THEIR PROCESS OF PRODUCTION AND THEIR PHARMACEUTICAL USE |
| 05/04/1994 | CN1086214A Di-and triazinediones |
| 05/03/1994 | US5308864 Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A |
| 05/03/1994 | US5308861 Therapeutic agent for treating atherosclerosis of mammals |
| 05/03/1994 | US5308852 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 05/03/1994 | US5308850 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 05/03/1994 | US5308846 Vision defects, hypotensive agents |
| 05/03/1994 | US5308844 Antidepressant, anxiolytic agent, analgesic, hypotensive agent |
| 05/03/1994 | US5308624 Ophthalmic product |
| 05/03/1994 | CA2108741A1 Androstane derivatives substituted by a quaternary ammonium group in 16- position, pharmaceutical compositions containing them and process for preparing same |
| 05/03/1994 | CA2102137A1 Heterocyclic compounds |
| 05/03/1994 | CA1329209C 2-amino-tetrahydro-isoquinoline derivatives and a process for the preparation thereof and pharmaceutical compositions containing same |
| 05/03/1994 | CA1329200C N-substituted n-nitrosoaminoacetonitriles, process for their preparation and their use |
| 05/03/1994 | CA1329123C Inhibitor of angiogenesis |
| 05/01/1994 | CA2109342A1 4-heterocyclophenyl-substituted dihydropyridines |
| 04/29/1994 | CA2107644A1 .alpha.-phosphonosulfonae squalene synthetase inhibitors and methd |
| 04/29/1994 | CA2107443A1 Benzo-fused lactams |
| 04/28/1994 | WO1994009116A1 Cho cells expressing human endothelin receptors |
| 04/28/1994 | WO1994009000A1 Quinoxalinedione derivatives as eaa antagonists |
| 04/28/1994 | WO1994008998A1 Imidazopyridine derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008996A1 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 04/28/1994 | WO1994008995A1 Heterocyclic condensed benzoic acid derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008994A1 Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008990A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders |
| 04/28/1994 | WO1994008989A1 N-arylheteroarylalkyl 1-cycloalkyl-imidazol-2-one compounds for treatment of circulatory disorders |
| 04/28/1994 | WO1994008965A1 N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008573A1 Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
| 04/28/1994 | CA2146930A1 Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146928A1 Imidazopyridine derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146923A1 Heterocyclic condensed benzoic acid derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146261A1 Sulfonamide derivatives of benzenefused, hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 04/28/1994 | CA2143193A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders |
| 04/28/1994 | CA2143192A1 N-arylheteroarylalkyl 1-cycloalkyl-imidazol-2-one compounds for treatment of circulatory disorders |
| 04/27/1994 | EP0594101A1 A process for the preparation of diltiazem |
| 04/27/1994 | EP0594022A1 Alkoxymethyl substituted pyridinone-biphenyls as angiotensin II antagonists |
| 04/27/1994 | EP0594019A1 Trisubstituted biphenyl as angiotensin II antagonistes |
| 04/27/1994 | EP0593603A1 Bicyclic fibrinogen antagonists |
| 04/27/1994 | EP0593520A1 Ocular compositions containing steroids and their use in treating glaucoma |
| 04/27/1994 | EP0505565B1 Quinoline derivatives, their production and use |
| 04/27/1994 | EP0460032B1 Novel vitamin d analogues |
| 04/27/1994 | CN1085899A 7-(2-aminoethyl)-benzothiazolones |
| 04/27/1994 | CN1085897A Angiotension II antagonists |
| 04/27/1994 | CN1085896A Angiotensin II antagonist imidazole derivatives, their preparation and their theapeutic use |
| 04/27/1994 | CN1024346C Antihypertensive 3-piperidinyl-indazole derivatives |
| 04/26/1994 | US5306817 Process for the stereospecific synthesis of azetidinones |
| 04/26/1994 | US5306732 Administering vinigrol |
| 04/26/1994 | US5306724 Administering L-2-oxothiazolidine-4-carboxylic acid to stimulate intracellular synthesis of glutathione |
| 04/26/1994 | US5306719 Carbostyril derivatives and salts thereof |
| 04/26/1994 | US5306503 Patch with a high content of softening ingredients |
| 04/26/1994 | CA1328878C Antihypercholesterolemic agents |
| 04/26/1994 | CA1328877C Antihypercholesterolemic agents |
| 04/26/1994 | CA1328866C Pyrazolo-pyrrolo-pyrimidine-diones |
| 04/25/1994 | CA2109025A1 Imidazopyridines |
| 04/24/1994 | CA2108950A1 A process for the preparation of diltiazem |